as 11-15-2024 4:00pm EST
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
Founded: | 1990 | Country: | United States |
Employees: | N/A | City: | MADISON |
Market Cap: | 171.0M | IPO Year: | 2007 |
Target Price: | $9.00 | AVG Volume (30 days): | 646.4K |
Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.17 | EPS Growth: | N/A |
52 Week Low/High: | $1.40 - $3.05 | Next Earning Date: | 11-06-2024 |
Revenue: | $444,204,000 | Revenue Growth: | -2.37% |
Revenue Growth (this year): | 6.33% | Revenue Growth (next year): | 5.60% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Pervaiz Ali | ARAY | SVP Chief Financial Officer | Sep 4 '24 | Sell | $2.06 | 8,404 | $17,276.10 | 394,138 |
ARAY Breaking Stock News: Dive into ARAY Ticker-Specific Updates for Smart Investing
Zacks
10 days ago
GuruFocus.com
11 days ago
Zacks
11 days ago
Zacks
11 days ago
Associated Press Finance
11 days ago
PR Newswire
11 days ago
Simply Wall St.
17 days ago
PR Newswire
25 days ago
The information presented on this page, "ARAY Accuray Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.